Kerstin Westritschnig

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Valneva Austria Gmbh, Valneva USA, Inc., Biomay Ag. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kerstin Westritschnig. Retrieved from https://idiyas.com/inventor/kerstin-westritschnig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

Biomay Produktions- Und Handelsaktiengesellschaft

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12324831 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2025-06-10),

2. 11478540 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2022-10-25),

3. 11357844 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2022-06-14),

4. 10821166 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2020-11-03),

5. 10357557 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2019-07-23),

6. 9598472 - [object Object] (2017-03-21),

7. 9296828 - Vaccine carrier (2016-03-29),

8. 7425333 - Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 (2008-09-16),

Title: Discovering the Innovations of Kerstin Westritschnig

Introduction

Kerstin Westritschnig is a prominent inventor based in Vienna, Austria, known for her significant contributions to the field of biotechnology. With a total of seven patents, she has focused on innovative solutions that address critical healthcare challenges. Her work showcases a dedication to advancing medical science through ingenious inventions.

Latest Patents

One of Westritschnig's latest patents includes the isolated polypeptide of the toxin A and toxin B proteins, which features C-TAB.G5 and C-TAB.G5.1. These isolated polypeptides include receptor binding domains of toxins A and B and are designed to neutralize the toxic effects of these harmful proteins. The specific amino acid sequences are detailed as SEQ ID NO: 2 and SEQ ID NO: 4, highlighting the precision and scientific rigor behind her work. This innovation holds promise for therapeutic applications in treating toxin-related conditions.

Career Highlights

Throughout her career, Westritschnig has contributed her expertise to notable companies, including Valneva Austria GmbH and Valneva USA, Inc. Her professional journey reflects her commitment to developing biopharmaceutical solutions that can make a meaningful impact on public health.

Collaborations

Kerstin has also collaborated with esteemed colleagues such as Larry R. Ellingsworth and David Flyer. These partnerships exemplify her ability to work alongside other experts in the field, fostering an environment of shared knowledge and innovation that propels scientific advancements.

Conclusion

Kerstin Westritschnig stands out as a leading inventor in biotechnology, with her patents demonstrating a focused approach to tackling the challenges posed by toxic proteins. Her innovative spirit and collaborative efforts continue to inspire progress in medical research and treatment solutions. As her work evolves, the impact of her inventions is expected to resonate within the scientific community and beyond.

Profile summary based on public USPTO records.